TGA grants provisional determination to Moderna’s COVID-19 bivalent (Original plus Omicron BA.4/BA.5) booster dose vaccine

30 September 2022 - On 28 September 2022, the TGA granted a provisional determination to Moderna's bivalent COVID-19 vaccine candidate: elasomeran ...

Read more →

TGA provisionally approves Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran) for use in children aged 6 months to less than 5 years

29 September 2022 - On 29 September 2022, the TGA provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran), ...

Read more →

European Medicines Agency accepts Moderna's conditional marketing authorisation filing for its Omicron BA.4/BA.5 targeting bivalent COVID-19 vaccine

28 September 2022 - Filing follows approval of Spikevax bivalent Original/Omicron BA.1 (mRNA-1273.214), a bivalent booster vaccine targeting the Omicron BA.1 ...

Read more →

COVID-19 vaccine procurement review says rapid access to vaccines and treatments key to on-going protection of Australians

27 September 2022 - Medicines Australia welcomes the independent review of Australia’s COVID-19 vaccine and treatment procurements by Professor Jane ...

Read more →

Pfizer and BioNTech submit application to U.S. FDA for Emergency Use Authorisation of Omicron BA.4/BA.5 adapted bivalent vaccine booster in children 5 through 11 years of age

26 September 2022 - Pfizer and BioNTech today announced they have completed a submission to the US FDA requesting Emergency Use ...

Read more →

Novavax appeals to ATAGI to change advice as vaccine uptake falls behind

25 September 2022 - Novavax was hailed as the fix to Australia’s low inoculation rate and “the vaccine for anti-vaxxers”. So ...

Read more →

ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years

26 September 2022 - Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged ...

Read more →

Moderna asks FDA to authorise omicron Covid boosters for children as young as 6 years old

23 September 2022 - The Centers for Disease Control and Prevention, in a document published Tuesday, said it expects children to ...

Read more →

COVID-19 vaccine safety report (23 September 2022)

23 September 2022 - To 18 September 2022, the TGA has received 712 reports which have been assessed as likely to ...

Read more →

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine

22 September 2022 - Pfizer said on Thursday it had submitted an application to Swissmedic for authorisation of a further ...

Read more →

EU health regulator says COVID pandemic not over

20 September 2022 - An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not ...

Read more →

TGA provisionally approves Pfizer's COVID-19 vaccine, Comirnaty (tozinameran), for use as a booster dose in individuals 5 years and older

21 September 2022 - On 20 September 2022, the TGA provisionally approved Pfizer's COVID-19 vaccine, Comirnaty (tozinameran) for use as ...

Read more →

Pharmacists can now prescribe Paxlovid, but barriers persist

19 September 2022 - Recently, the FDA expanded access to COVID-19 treatment by authorising state-licensed pharmacists to prescribe Paxlovid to eligible ...

Read more →

EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines

16 September 2022 - The EMA’s CHMP has recommended converting the conditional marketing authorisations of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer’s ...

Read more →

Take whatever COVID booster you can get, says head of EU drugs watchdog

14 September 2022 - People in Europe should take whatever COVID-19 booster is available to them in the coming months, ...

Read more →